BT Partnership

  • Viral gene

    Viral gene is a world-renowned vaccine development company developing unique cancer vaccine products.
    The GCC cancer vaccine under development in the Viral gene is the world's first new drug to use colorectal cancer marker. Its currently expected to enter US 2nd phase clinic.
    Alpha Holdings is investing in colorectal cancer vaccine R & D in collaboration with the Viral gene.